Prosecution Insights
Last updated: September 26, 2026
Application No. 18/865,299

DEVICES, SYSTEMS, AND METHODS FOR ULTRASOUND THERAPY

Final Rejection §103
Filed
Nov 12, 2024
Priority
May 13, 2022 — provisional 63/341,624 +1 more
Examiner
IP, JASON M
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
University of Kansas
OA Round
2 (Final)
55%
Grant Probability
Moderate
3-4
OA Rounds
1y 11m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allowance Rate
389 granted / 705 resolved
-14.8% vs TC avg
Strong +25% interview lift
Without
With
+25.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
25 currently pending
Career history
733
Total Applications
across all art units

Statute-Specific Performance

§101
4.4%
-35.6% vs TC avg
§103
55.5%
+15.5% vs TC avg
§102
12.7%
-27.3% vs TC avg
§112
26.6%
-13.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 705 resolved cases

Office Action

§103
DETAILED ACTION Notice of AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 09/03/2026 have been fully considered but they are moot in view of the new grounds of rejection. Allowable Subject Matter Claim 17 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 6-12, 15, 16, 19, 21 is/are rejected under 35 U.S.C. 103 as being unpatentable over Brouillette (US 20200383692). Regarding claims 1, 9, 10, 12, 15, 19, 21, Brouillette discloses a system and method, comprising: an ultrasound transducer ([0001]: “using mechanical waves, such as ultrasound”, [0002], Fig. 2: “mechanical wave source”); a catheter for insertion into a body lumen of a patient, the catheter including a distal end ([0072]); a reflective surface connected to the catheter near the distal end, the reflective surface formed from a material having an acoustic impedance mismatch with an adjacent material ([0075]: “acoustic impedance being greater than that of surroundings”; [0084]: “reflective external surface” of the attached inflatable balloon); and an inflatable element connected to the distal end of the catheter, wherein the reflective surface is positioned outside of an internal volume of the inflatable element, and wherein the inflatable element is inflatable within said body lumen (Figs. 1 and 2; [0084]: “a reflective external surface, such as an inflatable balloon”). Brouillette discloses that the acoustic energy source is positioned such that the target is between the acoustic energy source and the reflective surface (Figs. 1 and 2). Brouillette does not explicitly disclose that the inflatable element is used to move the reflective surface toward a target location within said body lumen. However, Brouillette does teach an inflatable balloon with a reflective external surface and when such a balloon is inflated against internal structures, the balloon would naturally move towards those structures. Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply the balloon to brace a reflective surface against a target as taught by Brouillette, as to provide a reflective surface near a target structure. Brouillette does not explicitly disclose targeting a “plaque deposit”, however Brouillette does teach a system where the mechanical waves introduced into the body are for the purpose of breaking up a target ([0068]: “cracks…ablate…cleaves or breaks”). Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply the mechanical waves to a plaque deposit, as to provide a therapeutic effect against plaque. Regarding claim 2, Brouillette discloses that the ultrasound transducer is separate from the catheter (Fig. 2). Regarding claim 3, Brouillette discloses that the ultrasound transducer is configured to be operated outside of said body lumen (Fig. 2). Regarding claims 6, 11, 16, Brouillette discloses that the reflective surface is an outside surface of the inflatable element [0084]: “reflective external surface” of the attached inflatable balloon). Regarding claim 7, Brouillette does not explicitly disclose a reflector connected to the distal end of the catheter, wherein the reflector is a different component from the inflatable element and wherein the reflector includes the reflective surface. However, Brouillette teaches that a reflective material may be a coating ([0032]). Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply a separate component in the form of a coating, as to provide a separation of elements in a system. Regarding claim 8, Brouillette does not explicitly disclose that the reflective surface is formed from a steel alloy. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply a steel allow because steel is a well-known acoustically reflective surface. Claim(s) 4, 5, 13, 14, 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Brouillette (US 2020/0383692), as applied to claims 1, 10, 15 above, in view of Zhou (US 20060241572, of record). Regarding claim 4, Brouillette does not explicitly disclose an optical energy source connected to the catheter, an emission end of the optical energy source located at the distal end of the catheter. However, Zhou teaches an optical energy source located at the distal end of a catheter (Fig. 4A, [0051]: “fiber 41” transmits laser light for ablation). Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply the laser of Zhou to the catheter of Brouillette, as to provide additional means of breaking down plaque deposits. Regarding claim 5, Brouillette does not explicitly disclose that the emission end is at least partially embedded in a reflector which includes the reflective surface. However, Zhou teaches an optical energy source located at the distal end of a catheter (Fig. 4A, [0051]: “fiber 41” transmits laser light for ablation). The structure of Zhou’s distal end and the reflective material of Emery would be readily combined since the material covers the entirety of the distal end. Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply the laser of Zhou to the catheter of Brouillette, as to provide additional means of breaking down plaque deposits. Regarding claims 13, 14, and 18, Brouillette does not explicitly disclose providing a sequence of laser pulses through an optical conduit to said plaque, simultaneous with the transmitting of ultrasound energy. However, Zhou teaches an optical energy source located at the distal end of a catheter (Fig. 4A, [0051]: “fiber 41” transmits laser light for ablation). Since the ultrasound and laser devices are separate devices, it would have been obvious that they may both be operated at the same time, to enhance the breakdown of the target structure. Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the present invention to apply the laser of Zhou to the catheter of Brouillette, as to provide additional means of breaking down plaque deposits. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jason Ip whose telephone number is (571) 270-5387. The examiner can normally be reached Monday - Friday 9a-5p PST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached on (571) 272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JASON M IP/Primary Examiner, Art Unit 3793
Read full office action

Prosecution Timeline

Nov 12, 2024
Application Filed
Jun 03, 2026
Non-Final Rejection mailed — §103
Sep 01, 2026
Examiner Interview Summary
Sep 01, 2026
Applicant Interview (Telephonic)
Sep 03, 2026
Response Filed
Sep 14, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740746
CLINICAL FITTING ASSISTANCE USING SOFTWARE ANALYSIS OF STIMULI
2y 6m to grant Granted Sep 22, 2026
Patent 12728293
ULTRASOUND-MEDIATED NEUROSTIMULATION
5y 7m to grant Granted Sep 08, 2026
Patent 12727846
BLOOD VELOCITY DETERMINATION
3y 3m to grant Granted Sep 08, 2026
Patent 12714292
OPTICAL UNIT AND ENDOSCOPE
2y 3m to grant Granted Aug 25, 2026
Patent 12718447
MOTION CORRECTION USING LOW RESOLUTION MAGNETIC RESONANCE IMAGES
2y 4m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
55%
Grant Probability
80%
With Interview (+25.2%)
3y 10m (~1y 11m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 705 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month